Want to join the conversation?
Biopharmaceutical company $ABBV secured FDA approval for IMBRUVICA as a first-line treatment for patients with CLL in 1Q16. In April, the company received FDA approval for Venclexta, another therapy for the treatment for CLL. Venclexta was approved for patients with relapsed/refractory CLL.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.